By the ZIVOLABS Medical Team · Updated April 2026 · 5 min read

This is one of the most searched questions about weight loss medication in India right now — and the confusion is understandable. "GLP-1" and "Ozempic" are used interchangeably in news articles, social media, and casual conversation. They are not the same thing, but the relationship between them is straightforward once explained.

GLP-1 is a class. Ozempic is a brand.

GLP-1 stands for Glucagon-Like Peptide-1. It is a hormone your body produces naturally, and more importantly in this context, it is the name of a class of medications — drugs that activate the same receptor that your natural GLP-1 hormone activates. The class is called GLP-1 receptor agonists.

There are several different GLP-1 medications — different molecules, different durations of action, taken in different ways:

Ozempic is the brand name Novo Nordisk gave to their specific semaglutide injection for diabetes. It is one product within the GLP-1 class — specifically the 0.5 mg and 1 mg weekly semaglutide injection.

So: Ozempic is a GLP-1 medication. But GLP-1 medication is not the same as Ozempic — just as "antibiotic" is a class and "amoxicillin" is one specific drug within that class.

Why do people say "Ozempic" when they mean GLP-1?

Because Ozempic was the first GLP-1 medication to become widely known to the general public — driven largely by media coverage of its weight loss effects (which were initially discovered as a secondary benefit during diabetes treatment). Celebrities and public figures discussing "Ozempic" created enormous search and social media volume around the brand name.

In the same way that "Google" became a verb for internet searching regardless of which search engine someone uses, "Ozempic" has become a popular shorthand for GLP-1 weight loss medication generally — even when the medication being discussed is actually semaglutide from a different manufacturer, or a different GLP-1 drug entirely.

What is the relevant distinction for Indian patients in 2026?

In the Indian market, the practically important distinction is not "GLP-1 vs Ozempic" but rather "Ozempic vs Indian generic semaglutide."

Ozempic (Novo Nordisk, imported) — available in limited supply through some private hospitals, expensive at ₹18,000–₹30,000/month, the original product.

Semasize (Alkem Laboratories, Indian, DCGI-approved) — the same molecule (semaglutide) at the same doses, manufactured in India, available at a fraction of the cost.

Semanat (Natco Pharma, Indian, DCGI-approved) — same molecule, same doses, Indian manufacturer.

All three are GLP-1 medications. All three contain semaglutide. The molecule is identical. The clinical effect is equivalent. The difference is manufacturer, origin, and price.

When your ZIVOLABS doctor prescribes semaglutide, you receive Semasize or Semanat — DCGI-approved Indian generics that are medically identical to Ozempic at a price that makes treatment accessible.

Frequently asked questions

Is Wegovy different from Ozempic? Both are semaglutide made by Novo Nordisk. Ozempic is the 0.5 mg and 1 mg weekly injection approved for Type 2 diabetes. Wegovy is the higher-dose version (up to 2.4 mg/week) approved specifically for weight management. Wegovy is not yet widely available in India.

Is tirzepatide (Mounjaro) a GLP-1 medication? Tirzepatide is a dual agonist — it activates both GLP-1 receptors and GIP (Glucose-dependent Insulinotropic Polypeptide) receptors. It is sometimes categorised under the GLP-1 class broadly and sometimes separately. It shows even greater weight loss than semaglutide in trials. It is not yet widely available in India as of 2026.

My doctor mentioned "GLP-1 therapy." Does that mean I will get Ozempic? In the Indian context in 2026, GLP-1 therapy almost certainly means DCGI-approved generic semaglutide — Semasize or Semanat — rather than imported Ozempic. This is medically equivalent and significantly more affordable.

If a celebrity said they used Ozempic, does that mean they used semaglutide? Yes. Ozempic contains semaglutide. If someone used Ozempic, they used semaglutide — specifically Novo Nordisk's branded version of it.

Summary

GLP-1 is the class. Ozempic is one specific branded product within that class. Semaglutide is the active molecule shared by Ozempic, Wegovy, Rybelsus, Semasize, and Semanat. In India in 2026, DCGI-approved generic semaglutide is the accessible, affordable, medically equivalent option.

[Check your eligibility for GLP-1 medication through ZIVOLABS →]

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified doctor before starting any new treatment.